GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » FCF Yield %

Curocell (XKRX:372320) FCF Yield % : -10.94 (As of May. 16, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Curocell FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Curocell's Trailing 12-Month Free Cash Flow is ₩-46,914.46 Mil, and Market Cap is ₩428,801.18 Mil. Therefore, Curocell's FCF Yield % for today is -10.94%.

The historical rank and industry rank for Curocell's FCF Yield % or its related term are showing as below:

XKRX:372320' s FCF Yield % Range Over the Past 10 Years
Min: -11.88   Med: 0   Max: 0
Current: -10.94


XKRX:372320's FCF Yield % is ranked better than
56.49% of 1556 companies
in the Biotechnology industry
Industry Median: -14.305 vs XKRX:372320: -10.94

Curocell's FCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.


Curocell FCF Yield % Historical Data

The historical data trend for Curocell's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell FCF Yield % Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
- - - - -9.63

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
FCF Yield % - - - -6.68

Competitive Comparison of Curocell's FCF Yield %

For the Biotechnology subindustry, Curocell's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curocell's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curocell's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Curocell's FCF Yield % falls into.



Curocell FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Curocell's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-46914.464 / 487334.66
=-9.63%

Curocell's annualized FCF Yield % for the quarter that ended in Jun. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-30628.682 * 2 / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curocell FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Curocell FCF Yield % Related Terms

Thank you for viewing the detailed overview of Curocell's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines